# Inhaled Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Post-Infectious Cough: A Single-Center Randomized Controlled Clinical Trial

> **NCT07103980** · PHASE1,PHASE2 · RECRUITING · sponsor: **Shanghai Changzheng Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Post-Infectious Cough

## Interventions

- **DRUG:** Mesenchymal stem cell derived exosome nebulization combined with compound methoxyphenamine capsule
- **DRUG:** Normal saline nebulization combined with the compound methoxyphenamine capsule

## Key facts

- **NCT ID:** NCT07103980
- **Lead sponsor:** Shanghai Changzheng Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-16
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07103980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07103980, "Inhaled Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Post-Infectious Cough: A Single-Center Randomized Controlled Clinical Trial". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT07103980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*